Table 3.
Survival data of 15 patients with appendiceal GCCs and PC
Survival | Data |
---|---|
Ad mortem, n (%) | 8 (53.3) |
Median overall survival after diagnosis of PC, range (months) | 28 (6.5–56) |
Median overall survival after CRS/HIPEC, range (months) | 17 (0.5–51) |
Abbreviations: CRS, cytoreductive surgery; GCCs, goblet cell carcinomas; HIPEC, hyperthermic intraperitoneal chemotherapy; PC, peritoneal carcinomatosis.